相关实验视频

Updated: Jan 17, 2026

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.

Published on: June 14, 2015

通过分子层面的合理设计,提高纤维素止血贴片的疗效

Fengting Yuan¹, Huan Zhang¹, Dong Zhang²

¹NMPA Key Laboratory for Quality Control of Blood Products, Academy of Military Medical Sciences, Beijing, China.

Thrombosis research

|January 14, 2026

概括

这项研究优化了纤维素静血贴片 (FHPs),通过精确平衡纤维素素,血栓素和化. 与现有产品相比,新型FHP在控制内部出血方面表现优越.

科学领域:

生物材料科学生物材料科学
血液静止研究血液静止研究
翻译医学是一种翻译医学.

背景情况:

内部出血是一种危及生命的疾病,需要迅速干预.
纤维素止血贴片 (FHPs) 为控制出血提供了一个有希望的解决方案.
优化FHPs的配方对于提高其有效性至关重要.

研究的目的:

开发一种具有改善凝血性能的新型纤维素静血贴片 (nFHP).
为了研究活性成分在FHP功能的固体比例的影响.
评估优化的nFHP在体内血液控制中的有效性.

主要方法:

系统查纤维素素,血栓素和化的度和比例.
使用优化的配方制造nFHP.
评估猪主动脉上纤维素网络的形成和粘合强度.
在肝切除,心脏刺伤和动脉出血模型中的体内评估.

主要成果:

纤维素度被确定为凝血时间的主要决定因素.
确定了最佳的nFHP配方 (17毫克/厘米2纤维素,40 IU/厘米2血栓,115μg/厘米2化物).
与商业FHP相比,nFHP表现出更快的纤维素网络形成和更高的粘合强度.
在体内研究表明,nFHP在多种出血模型中实现了最小的血液损失.

结论:

固体比例是纤维素基生物材料合理设计的关键因素.
开发的nFHP提供了一个可翻译和有效的解决方案,用于管理不受控制的内出血.
这项研究推动了下一代静血剂的开发.

关键词:

凝血因子凝血因子凝血因子纤维素补丁可以补充.血液静止血液静止血液静止理性的设计理性的设计.

更多相关视频

Engineering a Bilayered Hydrogel to Control ASC Differentiation

Engineering a Bilayered Hydrogel to Control ASC Differentiation

Published on: May 25, 2012

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections

Published on: October 31, 2017

相关概念视频

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...